Brazil’s $270 Million Vaccine Expansion: A Cautionary Tale for American Sovereignty and Public Health

As Brazil announces a hefty investment of nearly $270 million to modernize and expand the Instituto Butantan’s vaccine production facilities, Americans should not look away. While this South American nation doubles down on domestic pharmaceutical capabilities, the United States continues to grapple with fragile supply chains and overreliance on foreign sources for critical medicines. This story is more than an international report; it is a clear signal that national sovereignty in healthcare is not negotiable. Is America Prepared to Face the Next Health Crisis? The Brazilian government’s plan includes building two new factories, upgrading existing ones, and launching cutting-edge mRNA...